Stereotactic image‐guided microwave ablation of hepatocellular carcinoma using a computer‐assisted navigation system

Ablation plays an important role in the treatment of hepatocellular carcinoma. Because image‐guided navigation technology has recently entered the clinical setting, we aimed to analyse its safety, therapeutic and procedural efficiency.

[1]  T. George,et al.  Thermal ablation versus wedge or segmental resection in patients with early stage hepatocellular carcinoma: a population survival analysis. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[2]  R. Bale,et al.  Stereotactic Radiofrequency Ablation of Hepatocellular Carcinoma: a Histopathological Study in Explanted Livers , 2019, Hepatology.

[3]  W. Heerink,et al.  Liver microwave ablation: a systematic review of various FDA-approved systems , 2018, European Radiology.

[4]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[5]  Lukas P. Beyer,et al.  Stereotactically navigated percutaneous microwave ablation (MWA) compared to conventional MWA: a matched pair analysis , 2018, International Journal of Computer Assisted Radiology and Surgery.

[6]  Jeffrey A. Moscow,et al.  The evidence framework for precision cancer medicine , 2018, Nature Reviews Clinical Oncology.

[7]  Zhen Wang,et al.  Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta‐analysis , 2018, Hepatology.

[8]  M. Abecassis,et al.  AASLD guidelines for the treatment of hepatocellular carcinoma , 2018, Hepatology.

[9]  P. Nahon,et al.  Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations. , 2017, Journal of hepatology.

[10]  S. Fan,et al.  Randomized clinical trial of hepatic resection versus radiofrequency ablation for early‐stage hepatocellular carcinoma , 2017, The British journal of surgery.

[11]  Aya Kamaya,et al.  2017 Version of LI-RADS for CT and MR Imaging: An Update. , 2017, Radiographics : a review publication of the Radiological Society of North America, Inc.

[12]  S. Spiliopoulos,et al.  Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials , 2017, PloS one.

[13]  David D. Lee,et al.  Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium , 2017, Annals of surgery.

[14]  Liwen Liu,et al.  Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: a systematic review and meta-analysis , 2017, World Journal of Surgical Oncology.

[15]  Stefan Weber,et al.  Laparoscopic image-based navigation for microwave ablation of liver tumors—A multi-center study , 2017, Surgical Endoscopy.

[16]  Alexandre Moreau-Gaudry,et al.  Computer assisted electromagnetic navigation improves accuracy in computed tomography guided interventions: A prospective randomized clinical trial , 2017, PloS one.

[17]  C. Bureau,et al.  Outcomes of patients with hepatocellular carcinoma are determined in multidisciplinary team meetings , 2017, Journal of surgical oncology.

[18]  G. Toporek,et al.  Stereotactic CT-Guided Percutaneous Microwave Ablation of Liver Tumors With the Use of High-Frequency Jet Ventilation: An Accuracy and Procedural Safety Study. , 2017, AJR. American journal of roentgenology.

[19]  Stefan Weber,et al.  Intraoperative image-guided navigation system: development and applicability in 65 patients undergoing liver surgery , 2016, Langenbeck's Archives of Surgery.

[20]  J. Bruix,et al.  Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. , 2016, Gastroenterology.

[21]  H. Fukuda,et al.  Usefulness of US-CT 3D dual imaging for the planning and monitoring of hepatocellular carcinoma treatment using HIFU , 2016 .

[22]  Lukas P. Beyer,et al.  Robot-assisted microwave thermoablation of liver tumors: a single-center experience , 2016, International Journal of Computer Assisted Radiology and Surgery.

[23]  R. Lencioni,et al.  Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective , 2015, Liver Cancer.

[24]  P. Boelle,et al.  Early and resectable HCC: Definition and validation of a subgroup of patients who could avoid liver transplantation , 2015, Journal of surgical oncology.

[25]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[26]  Y. Paik,et al.  Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation: Risk Factors and Clinical Significance. , 2015, Radiology.

[27]  A. Ejaz,et al.  The Relative Net Health Benefit of Liver Resection, Ablation, and Transplantation for Early Hepatocellular Carcinoma , 2015, World Journal of Surgery.

[28]  Jijo Paul,et al.  Image-guided microwave thermoablation of hepatic tumours using novel robotic guidance: an early experience , 2015, European Radiology.

[29]  B. Isaksson,et al.  A multiple microwave ablation strategy in patients with initially unresectable colorectal cancer liver metastases - A safety and feasibility study of a new concept. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[30]  T. Vogl,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. , 2014, Journal of vascular and interventional radiology : JVIR.

[31]  L. Bolondi,et al.  Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[32]  M. Lee,et al.  Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes. , 2014, Radiology.

[33]  M. Choti,et al.  A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group , 2013, Annals of surgery.

[34]  M. Choi,et al.  Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. , 2013, Journal of hepatology.

[35]  F. Xia,et al.  A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. , 2012, Journal of hepatology.

[36]  G. Widmann,et al.  Stereotactic Radiofrequency Ablation (SRFA) of Liver Lesions: Technique Effectiveness, Safety, and Interoperator Performance , 2012, CardioVascular and Interventional Radiology.

[37]  H. Fukuda,et al.  Usefulness of US-CT 3D dual imaging for the planning and monitoring of hepatocellular carcinoma treatment using HIFU. , 2011, European journal of radiology.

[38]  Gerlig Widmann,et al.  Targeting accuracy of CT-guided stereotaxy for radiofrequency ablation of liver tumours , 2011, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[39]  K. D. de Jong,et al.  Liver Resection Combined with Local Ablation: Where Are the Limits , 2011, Digestive Surgery.

[40]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[41]  Yun Ku Cho A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. , 2011, Annals of surgery.

[42]  Yong Zeng,et al.  A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria , 2010, Annals of surgery.

[43]  W. Xie,et al.  Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta‐analysis , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[44]  T. Kawabe,et al.  Radiofrequency ablation for hepatocellular carcinoma in so‐called high‐risk locations , 2006, Hepatology.

[45]  W. Lau,et al.  A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma , 2006, Annals of surgery.

[46]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[47]  D. Woodfield Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[48]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .